HiFiBiO Therapeutics
MA - Cambridge
Biotechnology1 H-1B visas (FY2023)Focus: Single cell technologies for drug discovery
HiFiBiO Therapeutics is a life sciences company focused on Single cell technologies for drug discovery.
Oncology
Open Jobs
0
Pipeline & Clinical Trials
HFB30132A
HealthyClinical Trials (1)
NCT05275660A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Healthy Adults
Phase 1HFB200603
Renal Cell CarcinomaClinical Trials (1)
NCT05789069A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
Phase 1HFB301001
Soft Tissue SarcomaClinical Trials (1)
NCT05229601A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Phase 1HFB30132A
HealthyClinical Trials (1)
NCT04590430Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults
Phase 1HFB200301
Gastric CancerClinical Trials (1)
NCT05238883A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
Phase 1Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2017
Portfolio: 5 clinical trials
H-1B (2023): 1 approval
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub